card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Choosing HRMS vs LBA for Bioanalysis

Presented by Adriane Spytko, Associate Director – LCMS Biologics, during the 2023 AAPS Summer Scientific Forum
Home / Insights / Choosing HRMS vs LBA for Bioanalysis

There is an increase in the complexity of drug modalities along with the need for more sensitive methods.  Immunoassays, while often chosen as the first platform to utilize for assessing pharmacokinetics of biologics, are entirely dependent on critical reagents. Multi-dimensional low-flow chromatography coupled to high resolution mass spectrometry can be advantageous for instances where a high degree of sensitivity or greater selectivity is required, or when higher quality critical reagents are not available.

 

Learning Objectives:

  • When to choose LCMS over LBA for bioanalysis considering the availability of critical reagents and the need for sensitivity and selectivity
  • Understanding the advantages of multi-dimensional LC/HRMS in the context of regulated bioanalysis
  • Takeaways from case studies showing the advantages of LCMS over LBA where greater sensitivity or selectivity was needed